Sun Pharma shares in focus after Q4 profit drops 19% YoY to Rs 2,154 crore

Sun Pharma’s Q4 consolidated net profit fell 19% YoY to ₹2,154 crore, despite an 8% rise in revenue to ₹12,959 crore. Sequentially, both profit and revenue declined. For FY25, net profit rose to ₹10,965 crore. The company reported exceptional charges related to a U.S. settlement. Shares slipped 0.7% amid mixed financial results.

ITC shares in focus after Q4 adjusted PAT rises 3% YoY to Rs 5,155 crore

ITC’s Q4 adjusted PAT rose 3% YoY to Rs 5,155 crore, driven by strong performance in the FMCG-Cigarettes and Agri Business segments. Revenue grew 10% to Rs 20,376 crore. However, some segments like FMCG-Others and Paperboards saw profit declines. The headline profit surged due to exceptional gains, keeping ITC shares in focus.

Bitcoin tops $110,000 for first time as US optimism lifts crypto

Bitcoin has crossed $110,000, reaching a new record. Optimism grew after US senate considered a stablecoin bill. Michael Saylor’s Strategy and other digital-asset firms are buying Bitcoin. Some companies are using bonds and stocks to fund purchases. Traders are focusing on Bitcoin positions expiring in June. Experts suggest a sustained break above $110,000 could lead to $125,000.

RVNL shares in focus after Q4 profit dips 4% YoY to Rs 459 crore

Rail Vikas Nigam Limited (RVNL) reported a 4% YoY decline in Q4 net profit to Rs 459 crore, with revenue down 4.3%. Despite a slight dip in EBITDA margin, RVNL declared a final dividend of Rs 1.72 per share. Analysts remain cautious, with an average target price of Rs 339 and a ‘Sell’ consensus rating.

Financials still in play, but rotation towards quality largecaps underway: Jigar Mistry

Jigar Mistry of Buoyant Capital favors healthcare, materials, chemicals, and banking sectors, preferring large-cap private banks over PSU banks. He remains positive on both generic and CDMO pharma segments, dismissing tariff concerns. Mistry believes valuations are elevated, especially for narrative-driven stocks lacking earnings, advocating for a focus on fundamentals over market flows.